Product Name
Pentoxifylline
Description
Pentoxifylline (BL-191), a haemorheological agent, is an orally active non-selective phosphodiesterase (PDE) inhibitor, with immune modulation, anti-inflammatory, hemorheological, anti-fibrinolytic and anti-proliferation effects. Pentoxifylline can be used for the research of peripheral vascular disease, cerebrovascular disease and a number of other conditions involving a defective regional microcirculation.
Synonyms
TRENTAL;1-(5-Oxohexyl)-3,7-dimethylxanthine;1-(5-oxohexyl)-theobromin;1-(5-Oxohexyl)theobromine;1-(5-oxohexyl)-Theobromine;1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-;3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-1h-purine-6-dione;3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione
Molecular Formula
C13H18N4O3
Canonical SMILES
O=C(N1CCCCC(C)=O)N(C)C2=C(N(C)C=N2)C1=O
Storage
Powder-20°C, 3 years; 4°C, 2 years; In solvent-80°C, 6 months; -20°C, 1 month.
Shipping
Can be shipped at room temperature, where not in use may vary.